In addition, SCD1 protects the liver by inhibiting iron death, and SCD1 inhibits iron death by down-regulating lipid peroxide production that induces iron death, which promotes NAFLD (Liu et al., 2021; Chen et al., 2022). Here, SCD is linked to metabolic dysfunction-associated steatotic liver disease.